Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma

Chinese Medical Journal

Volumn 120, Issue 6, 2007, Pages 515-521

  Guo, Hua ^a   Zhang, Hong Ying ^b   Wang, Shou Li ^b,c   Ye, Lü ^b   Yang, Guang Hua ^b   Bu, Hong ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

Mitogen activated prtein kinase; Rhabdomyosarcoma; Smad4; Transforming growth factor beta1

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CANCER INVASION; CANCER TISSUE; CARCINOGENESIS; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MYOBLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SARCOMA CELL; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 34047180525     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200703020-00016     Document Type: Article

References (29)

1. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000; 14: 627-644.
2. Kim HP, Lee MS, Yu J, Park JA, Jong HS, Kim TY, et al. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity. Biochem J 2004; 379: 141-150.
3. Wong SF, Lai LC. The role of TGF beta in human cancers. Pathology 2001; 33: 85-92.
4. Yang W, Chen Y, Zhang Y, Wang X, Yang N, Zhu D. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. Cancer Res 2006; 66: 1320-1326.
5. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40.
6. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-1912.
7. Blanchette F, Rivard N, Rudd P, Grondin F, Attisano L, Dubois CM. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta1-induced furin gene transactivation. J Biol Chem 2001; 276: 33986-33994.
8. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000; 1: 169-178.
9. Fletcher CD, Unni KK, Metrens F. World Health Organization Classification of Tumours: pathology and genetics of tumours of soft tissue and bone. IARC Press: Lyon 2002; 146-154.
10. Wang H, Yang GH, Bu H, Zhou Q, Guo LX, Wang SL, et al. Systematic analysis of the TGF-beta/smad signalling pathway in the rhabdomyosarcoma. cell line RD. Int J Exp Pathol 2003; 84: 153-163.
11. McAllister RM, Melnyk J, Finkelstein JZ, Adams EC Jr, Gardner MB. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 1969; 24: 520-526.
12. Molenaar WM, Oosterhuis JW, Kamps WA. Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol 1984; 15: 973-979.
13. Pappo AS, Shapiro DN, Crist WM. Rhabdomyosarcoma. Biology and treatment. Pediatr Clin North Am 1997; 44: 953-972.
14. Dagher R, Helman L. Rhabdomyosarcoma: an overview. Oncologist 1999; 4: 34-44.
15. Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 2005; 24: 5742-5750.
16. Watkins SJ, Jonker L, Arthur HM. A direct interaction between TGF beta activated kinase 1 and the TGF beta type II receptor: Implications for TGF beta signalling and cardiac hypertrophy. Cardiovasc Res 2006; 69: 432-439.
17. Lenormand P, Brondello JM, Brunet A, Pouyssegur J. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J Cell Biol 1998; 142: 625-633.
18. Moustakas A, Heldin CH. Non-Smad TGF-beta signals. J Cell Sci 2005; 118: 3573-3584.
19. Simeone DM, Zhang L, Graziano K, Nicke B, Pham T, Schaefer C, et al. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells. Am J Physiol Cell Physiol 2001; 281: C311-C319.
20. Finlay GA, Thannickal VJ, Fanburg BL, Paulson KE. Transforming growth factor-beta1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J Biol Chem 2000; 275: 27650-27656.
21. Watanabe H, de Caestecker MP, Yamada Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 2001; 276: 14466-14473.
22. Alabert C, Rogers L, Kahn L, Niellez S, Fafet P, Cerulis S, et al. Cell type-dependent control of NF-Y activity by TGF-beta. Oncogene 2006; 25: 3387-3396.
23. Jankowski K, Kucia M, Wysoczynski M, Reca R, Zhao D, Trzyna E, et al. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res 2003; 63: 7926-7935.
24. Mauro A, Ciccarelli C, De Cesaris P, Scoglio A, Bouche M, Molinaro M, et al. PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J Cell Sci 2002; 115: 3587-3599.
25. Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, et al. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3′-kinase-Akt signaling pathways. Cancer Res 2003; 63: 364-374.
26. Imamichi Y, Waidmann O, Hein R, Eleftheriou P, Giehl K, Menke A. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4. Biol Chem 2005; 386: 225-236.
27. Brown JD, DiChiara MR, Anderson KR, Gimbrone MA Jr, Topper JN. MEKK-1, a component of the stress (stress activated protein kinase/c-jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem 1999; 274: 8797-8805.
28. Kretzschmar M, Doody J, Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 1997; 389: 618-622.
29. Dai JL, Schutte M, Bansal RK, Wilentz RE, Sugar AY, Kern SE. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells. Mol Carcinog 1999; 26: 37-43.